The effect of **Naftidrofuryl (Nafronyl) on the symptoms of severe peripheral vascular disease has been studied in 40 hospital inpatients. Assess ment of ischaemic symptoms and of symptoms which may occur with any type of chronic pain was made using a linear analogue system. Patients treated with naftidrofuryl showed a significant symptomatic improvement compared to patients treated without vasoactive drug therapy. These results show that this drug has a useful place in the treatment of severe ischaemic symptoms during assessment for vascular reconstruction and in those patients found to be unsuitable for limb-salvage operations.
Get full access to this article
View all access options for this article.
References
1.
Bond MR and Pilowsky I.: Subjective assessment of pain and its relationship to the administration of analgesics in patients with advanced cancer. J Psychosom Res10:203, 1966.
2.
Mehta M.: Assessment of Pain. In: The Anatomy of Pain, ed. by E. Lonbay, Bastingstoke, Dista Products Ltd., 1978, book 1 part 2.
3.
Melzack R.: The Puzzle of Pain. New York, Basic Books, 1973.
4.
Gracely RH, Dubner R., McGrath P. and Heft M.: New methods of pain measurement and their application to pain control. Int Dent J28:52, 1977.
5.
Berry H. and Huskisson EC: Treatment of Rheumatoid arthritis, a trial of meprothixal. Clinical Trials J9:13, 1972.
6.
Chapman CR: Measurement of pain, problems and issues. In: Advances in Pain Research and Therapy, Ed. by J J Bonica and D Albe-Fessard, New York , Raven Press, 1976, Vol. 1.
7.
Clark Prf and Spear FB: Reliability and sensitivity in the self assessment of wellbeing. Bull Brit Psychol Soc17:155, 1964.
8.
Downie WW, Leatham PA, Rhind VM, et al: Studies with pain rating scales. Ann Rheum Dis37:378, 1978.
9.
Mansel RE, Preece PE and Hughes LE: A double blind trial of the prolactin inhibiter bromocriphine in painful benign breast disease. Br J Surg65:724, 1978.
10.
Revill SI, Robinson JO, Rosen M. and Hogg Mij: The reliability of a linear analogue for evaluating pain. Anaesthesia31:1191, 1976.
11.
Aitken Rcb: Measurement of feelings using visual analogue scales. Proc Roy Soc Med62:989, 1969.
12.
Huskisson EC: Pain—Mechanisms and Measurement. In: The Treatment of Chronic Pain, ed. by F Dudley Hart, Lancaster, Medical and Technical Publishing Co Ltd , 1974.
13.
Pilowsky I. and Kaufman A.: An experimental study of atypical phantom pain. Br J Psychiatry111:1185, 1965.
14.
Elert C., Niebel W., Karuse E. and Satter P.: Beeinflussing des Energiestoffwechsels der Minderdurchbluteten extremitatenmuskulatur durch Naftidrofuryl. Therapiewoche26:3947, 1976.
15.
Shaw Swj and Johnson RH: The effect of Naftidrofuryl on the metabolic response to exercise in man. Acta Neurol Scand52:231, 1975.
16.
Haavik Nilsen K: The effects of Naftidrofuryl on microcirculatery cold sensitivity in Raynauds phenomenon. Br Med J1:20, 1979.
17.
Hauch E. and Levai Z.: Klinische Erfahrungen mit Naftidrofuryl bei peripheren arteriellen Durchblutungsstorungen . Med Welt24:1665, 1973.
18.
Kreissman A. and Radler M.: Anderung der Unterschenkeldurchblutung wahrend oraler Behandlung mit Naftidrofuryl. Munch Med Wschr, 115:508, 1973.
19.
Fontaine L. , Grand M., Szarvasi E. and Bassat M.: A study of the vasodilater effect of Naftidrofuryl . Bulletin Chimie Therapeutique, 1:39, 1969.
20.
Heidrich H. , Barckaw D., Grand M. and Fontaine L.: Klinische and tierexperimentale Untersuchungen zur hamodynamischen Wirkungsweise von Naftidrofuryl. Arzneim Forsch22:1001, 1972.
21.
Ratschow R. : Konservative Therapie arterieller Veischluss krankheiten mit Naftidrofuryl hydrogenoxalat. Munch Med Wschr118:1131, 1976.
22.
Savi L., Dal Lago A., Serricchio H. and Pola P.: The effect of naftidrofuryl upon blood and plasma viscosity and upon plasma fibrinogen levels. Vie Medicale Vol 4, 285, 1979.
23.
Greenhalgh RM and Hoare M.: The effect of Naftidrofuryl on patients with ischaemic rest pain. Presentation to Vascular Surgical Society of Great Britain and Ireland, Edinburgh, November 18, 1977.
24.
Hepp G., Lennert KA and Brandt K.: Veranderungen des Kapillarmikroskopischen bildes bei arterrosklerotischen Durchblutungsstorungen. Munch Med Wschr114:565, 1972.
25.
Sherer HJ, Mack D., Maurer P. and Brauer S.: Praxilene—Indicateur pre-operataire pour la sympathectomic lombaire dan l'arterite chronique des membres inferieur. Lyon Chirurgurical69:280, 1973.
26.
Scherer HJ, Maurer PC, Mack D., et al: Unterstutzende Behandlung peripherer chronisch—arterieller durchblutungsstorungen in der Gefasschirurgie mit Naftidrofuryl. Therapiewoche37:3307, 1973.
27.
Bianchi G.: Esperienze cliniche in doppio cierco con L S 121 in pazienti portatori di sindromi ischemiche chroniche periferiche. Minerva Chirurigica29:885, 1972.
28.
Clyne MB and Lask A.: A single blind study of Niftidrofuryl in the treatment of peripheral vascular disorders in general practice. Br J Clin Pract32:169, 1978.
29.
Delomier Y. and Garapon G.: Naftidrofuryl oxalate solute injectable contre solute isotonique de chlorure de sodium a 9%— essai en double aveugle. Revue deMedicine17:541, 1976.
30.
Ruckley CVCallam MJ, Ferrington CM and Prescott RJ: Naftidrofuryl for intermittent claudication: a double blind controlled trial . Brit Med J1:622, 1978.
31.
Clyne Cac, Galland RB, Fox MJ, et al: A controlled trial of Naftidrofuryl in the treatment of intermittent claudication. Br J Surg67:347, 1980.
32.
Waters KJ, Craxford AD, Chamberlain J.: The effect of Naftidrofuryl on intermittent claudication. Br J Surg67:349, 1980.
33.
Wong AL and McBain GC: The importance of Personality Measurement in the assessment of response to treatment for ischaemic rest pain. Brit J Surg67:509, 1980.
34.
Meehan SE, Walker WF and Cuschieri A.: Skin pH measurement—A new method of assessment in peripheral vascular disease. Presentation to XVth Congress of the European Society for Surgical Research, Brussels, Belgium 1980.
35.
Becker HM: Naftidrofuryl, eine neue gefassaktive Substanz in der vorbereitenden Arterien—Gefasschirurgie . Med Klin65:359, 1970.
